Food-sourced microbiome drugs get $101M megaround for Flagship's Kaleido
Mining food for safer sources of chemistry, microbiome startup Kaleido has closed a $101 million megaround to push its pipeline through the clinic.
The company …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
